Pharmaceuticals

NICE Blocks J&J Prostate Cancer Drug Abiraterone

NICE Blocks J&J Prostate Cancer Drug Abiraterone

National Institute for Health and Care Excellence (NICE) has decided to block Johnson & Johnson’s prostate cancer drug. In an official communication, NICE informed that it is not worth giving the medicine to patients who have not received chemotherapy. The Institute of Cancer Research (ICR) health experts had suggested abiraterone acetate for men before they undergo chemotherapy.

Location: 
Laboratories: 

Evolocumab and Statin Therapy Reduces LDL Cholesterol by 75 Percent: AMGEN

Evolocumab and Statin Therapy Reduces LDL Cholesterol by 75 Percent: AMGEN

Pharmaceutical major Amgen has announced Phase 3 LAPLACE-2 results, with 63 to 75 percent reduction in LDL cholesterol levels. The multiple-location clinical trial has found subcutaneous evolocumab along with statin medication very effective in LDL-C levels.

The results have been published in the Journal of the American Medical Association May 14 issue. The study findings were earlier announced at American College of Cardiology's 63rd Annual Scientific Session in March this year.

Location: 
Laboratories: 
Company: 

Anti-Clotting drug Zontivity Approved by FDA for Heart Attacks

Anti-Clotting drug Zontivity Approved by FDA for Heart Attacks

The U.S. FDA has approved Merck anti-clotting drug Zontivity (vorapaxar) for high-risk group of heart patients. The drug has been recommended for reducing cardiovascular ailment related deaths and stroke.

The drug will be sold under brand name Zontivity in the United States. In January, the FDA panel had voted 10-1 in favor of the drug approval for heart attacks and stroke patients. The delay is approval was due to further checks by FDA team regarding the reports of fatal bleeding among some patients.

Location: 
Laboratories: 
Company: 

Vibrating Capsule from Israel Helps in Constipation

Vibrating Capsule from Israel Helps in Constipation

Many people suffer from constipation and there are numerous natural and medical remedies for the ailment. However, in certain cases of chronic constipation, the individuals suffer from other ailments related to constipation as well. Israel based pharmaceutical company Vibrant has come up with a vibrating capsule, which could help people suffering from constipation.

Location: 

FDA Panel Rejects OTC allergy drug Singulair

FDA Panel Rejects OTC allergy drug Singulair

The U.S. FDA panel has rejected Merck’s application for approval of its prescription drug Singulair as over the counter medication. The FDA panel voted 11-4 against the asthma and allergies drug Singulair.

Singulair has been a blockbuster drug for Merck for years. However, the sales have dropped as the patent expired in 2012. The generic versions are available at lower price and Merck aimed at OTC status for the drug to revive sales.

Location: 
Laboratories: 
Company: 

FDA Gives Early Approval to Novartis Drug for Lung Cancer

FDA Gives Early Approval to Novartis Drug for Lung Cancer

A new drug for the treatment of non-small cell lung cancer has sought the approval from the US Food and Drug Administration (FDA) on Tuesday.

Location: 
Company: 

Sarepta Drug Eteplirsen to be Reviewed by FDA under Accelerated Approval Pathway

Sarepta Drug Eteplirsen to be Reviewed by FDA under Accelerated Approval Pathway

Sarepta Therapeutics announced that U.S. FDA has indicated alternate path to approval for its muscle disorder drug. The experimental drug to arrest the progression of Duchenne muscular dystrophy in young boys was not able to convince the FDA panel over the last few months. The latest news has raised fresh hope for the approval of the drug. Sarepta Therapeutics stock jumped nearly 64 percent in the stock market after the positive news.

Laboratories: 

Experimental Hepatitis Drug Cures 95% Patients in Clinical Trial: German Researchers

Experimental Hepatitis Drug Cures 95% Patients in Clinical Trial

German and US Research team has announced 95 percent success rate for an experimental drug for treatment of Hepatitis C. The drug has been found effective even in patients who failed to respond to earlier treatment. The experimental drug therapy has been reported to be better-tolerated by patients, over a period of three months compared to interferon treatment which generally requires one year.

Laboratories: 
Company: 

Singapore to Check Tamiflu after UK based Cochrane Collaboration Report on Tamiflu

Singapore to Check Tamiflu after UK based Cochrane Collaboration Report on Tamif

The Ministry of Health in Singapore has planned to start an investigation regarding the positive impact of Roche AG’s Tamiflu and GSK’s Relenza in controlling flu. UK based non-profit organization Cochrane Collaboration had reported earlier this week that tamiflu and relenza were not found effective after their reviewed 170,000 pages of clinical trial data.

Biogen Idec Blood Disorder Drug Registers Positive Outcomes for Phase 3 Trials

Biogen Idec Blood Disorder Drug Registers Positive Outcomes for Phase 3 Trials

Biogen Idec and Swedish Orphan Biovitrum AB have registered positive outcomes for phase 3 trials of experimental drug for hemophilia A. The clinical trial has found high success rate among children suffering from blood disorder in maintaining low bleeding rates.

Biogen Idec announced that the experimental drug ELOCTATE was tested for efficacy and safety in the clinical trial carried out of children under 12 years of age. Swedish Orphan Biovitrum developed using Fc fusion process. The drug claims to prolong the circulation of infused clotting factor.

Location: 
Company: 

Pages

Popular Stories

Harley-Davidson to turn 8 Dyna motorbikes into new Softail bikes

Betting big on cruisers, the luxury motorcycle... Read More

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More

Tesla announces risky new approach to customer service

During the past few years, Tesla was slammed by a... Read More